0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parkinson Disease Drug Market Size, Status and Forecast 2019-2025
Published Date: May 2019
|
Report Code: QYRE-Auto-381
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Parkinson Disease Drug Market Size Status and Forecast 2019 2025

Global Parkinson Disease Drug Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-381
Report
May 2019
103 Pages
QYResearch
Region: Global, Europe,
Description
Table of Content
Tables & Figures
In 2018, the global Parkinson Disease Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson Disease Drug development in United States, Europe and China.

The key players covered in this study
    Merck
    Akorn
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Valeant Pharmaceuticals

Market segment by Type, the product can be split into
    Sinemet-CR
    Trastal
    Madopar
    COMT Inhibitor
    Other

Market segment by Application, split into
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players.
    To present the Parkinson Disease Drug development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson Disease Drug are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Parkinson Disease Drug Market Size Growth Rate by Type (2014-2025)
        1.4.2 Sinemet-CR
        1.4.3 Trastal
        1.4.4 Madopar
        1.4.5 COMT Inhibitor
        1.4.6 Other
    1.5 Market by Application
        1.5.1 Global Parkinson Disease Drug Market Share by Application (2014-2025)
        1.5.2 Under 40 Years Old
        1.5.3 40-65 Years Old
        1.5.4 Above 65 Years Old
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Parkinson Disease Drug Market Size
    2.2 Parkinson Disease Drug Growth Trends by Regions
        2.2.1 Parkinson Disease Drug Market Size by Regions (2014-2025)
        2.2.2 Parkinson Disease Drug Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Parkinson Disease Drug Market Size by Manufacturers
        3.1.1 Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019)
        3.1.2 Global Parkinson Disease Drug Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Parkinson Disease Drug Key Players Head office and Area Served
    3.3 Key Players Parkinson Disease Drug Product/Solution/Service
    3.4 Date of Enter into Parkinson Disease Drug Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Parkinson Disease Drug Market Size by Type (2014-2019)
    4.2 Global Parkinson Disease Drug Market Size by Application (2014-2019)

5 United States
    5.1 United States Parkinson Disease Drug Market Size (2014-2019)
    5.2 Parkinson Disease Drug Key Players in United States
    5.3 United States Parkinson Disease Drug Market Size by Type
    5.4 United States Parkinson Disease Drug Market Size by Application

6 Europe
    6.1 Europe Parkinson Disease Drug Market Size (2014-2019)
    6.2 Parkinson Disease Drug Key Players in Europe
    6.3 Europe Parkinson Disease Drug Market Size by Type
    6.4 Europe Parkinson Disease Drug Market Size by Application

7 China
    7.1 China Parkinson Disease Drug Market Size (2014-2019)
    7.2 Parkinson Disease Drug Key Players in China
    7.3 China Parkinson Disease Drug Market Size by Type
    7.4 China Parkinson Disease Drug Market Size by Application

8 Japan
    8.1 Japan Parkinson Disease Drug Market Size (2014-2019)
    8.2 Parkinson Disease Drug Key Players in Japan
    8.3 Japan Parkinson Disease Drug Market Size by Type
    8.4 Japan Parkinson Disease Drug Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Parkinson Disease Drug Market Size (2014-2019)
    9.2 Parkinson Disease Drug Key Players in Southeast Asia
    9.3 Southeast Asia Parkinson Disease Drug Market Size by Type
    9.4 Southeast Asia Parkinson Disease Drug Market Size by Application

10 India
    10.1 India Parkinson Disease Drug Market Size (2014-2019)
    10.2 Parkinson Disease Drug Key Players in India
    10.3 India Parkinson Disease Drug Market Size by Type
    10.4 India Parkinson Disease Drug Market Size by Application

11 Central & South America
    11.1 Central & South America Parkinson Disease Drug Market Size (2014-2019)
    11.2 Parkinson Disease Drug Key Players in Central & South America
    11.3 Central & South America Parkinson Disease Drug Market Size by Type
    11.4 Central & South America Parkinson Disease Drug Market Size by Application

12 International Players Profiles
    12.1 Merck
        12.1.1 Merck Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Parkinson Disease Drug Introduction
        12.1.4 Merck Revenue in Parkinson Disease Drug Business (2014-2019)
        12.1.5 Merck Recent Development
    12.2 Akorn
        12.2.1 Akorn Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Parkinson Disease Drug Introduction
        12.2.4 Akorn Revenue in Parkinson Disease Drug Business (2014-2019)
        12.2.5 Akorn Recent Development
    12.3 GSK
        12.3.1 GSK Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Parkinson Disease Drug Introduction
        12.3.4 GSK Revenue in Parkinson Disease Drug Business (2014-2019)
        12.3.5 GSK Recent Development
    12.4 Novartis
        12.4.1 Novartis Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Parkinson Disease Drug Introduction
        12.4.4 Novartis Revenue in Parkinson Disease Drug Business (2014-2019)
        12.4.5 Novartis Recent Development
    12.5 Boehringer Ingelheim
        12.5.1 Boehringer Ingelheim Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Parkinson Disease Drug Introduction
        12.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)
        12.5.5 Boehringer Ingelheim Recent Development
    12.6 Teva Pharmaceutical
        12.6.1 Teva Pharmaceutical Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Parkinson Disease Drug Introduction
        12.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)
        12.6.5 Teva Pharmaceutical Recent Development
    12.7 Abbvie
        12.7.1 Abbvie Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Parkinson Disease Drug Introduction
        12.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)
        12.7.5 Abbvie Recent Development
    12.8 Kyowa Hakko Kirin Pharma
        12.8.1 Kyowa Hakko Kirin Pharma Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Parkinson Disease Drug Introduction
        12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
        12.8.5 Kyowa Hakko Kirin Pharma Recent Development
    12.9 Astellas Pharma
        12.9.1 Astellas Pharma Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Parkinson Disease Drug Introduction
        12.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
        12.9.5 Astellas Pharma Recent Development
    12.10 Desitin Arzneimittel
        12.10.1 Desitin Arzneimittel Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Parkinson Disease Drug Introduction
        12.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)
        12.10.5 Desitin Arzneimittel Recent Development
    12.11 Endo Pharmaceuticals
    12.12 F.Hoffmann-La Roche
    12.13 H.Lundbeck
    12.14 Valeant
    12.15 Apokyn
    12.16 Orion
    12.17 Stada Arzneimittel
    12.18 US WorldMeds
    12.19 Valeant Pharmaceuticals

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table Parkinson Disease Drug Key Market Segments
    Table Key Players Parkinson Disease Drug Covered
    Table Global Parkinson Disease Drug Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Parkinson Disease Drug Market Size Market Share by Type 2014-2025
    Figure Sinemet-CR Figures
    Table Key Players of Sinemet-CR
    Figure Trastal Figures
    Table Key Players of Trastal
    Figure Madopar Figures
    Table Key Players of Madopar
    Figure COMT Inhibitor Figures
    Table Key Players of COMT Inhibitor
    Figure Other Figures
    Table Key Players of Other
    Table Global Parkinson Disease Drug Market Size Growth by Application 2014-2025 (Million US$)
    Figure Under 40 Years Old Case Studies
    Figure 40-65 Years Old Case Studies
    Figure Above 65 Years Old Case Studies
    Figure Parkinson Disease Drug Report Years Considered
    Table Global Parkinson Disease Drug Market Size 2014-2025 (Million US$)
    Figure Global Parkinson Disease Drug Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Parkinson Disease Drug Market Size by Regions 2014-2025 (Million US$)
    Table Global Parkinson Disease Drug Market Size by Regions 2014-2019 (Million US$)
    Table Global Parkinson Disease Drug Market Share by Regions 2014-2019
    Figure Global Parkinson Disease Drug Market Share by Regions 2014-2019
    Figure Global Parkinson Disease Drug Market Share by Regions 2019
    Table Market Top Trends
    Table Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Share by Manufacturers (2014-2019)
    Figure Global Parkinson Disease Drug Market Share by Manufacturers in 2018
    Table Global Parkinson Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Parkinson Disease Drug Product/Solution/Service
    Table Date of Enter into Parkinson Disease Drug Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Size Share by Type (2014-2019)
    Figure Global Parkinson Disease Drug Market Size Market Share by Type (2014-2019)
    Table Global Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Size Share by Application (2014-2019)
    Figure Global Parkinson Disease Drug Market Size Market Share by Application (2014-2019)
    Figure Global Parkinson Disease Drug Revenue Market Share by Application in 2018
    Figure United States Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table United States Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table United States Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table United States Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table United States Parkinson Disease Drug Market Share by Type (2014-2019)
    Table United States Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table United States Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Europe Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Europe Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Europe Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Europe Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Europe Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Europe Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Europe Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure China Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table China Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table China Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table China Parkinson Disease Drug Market Size by Type (2014-20189) (Million US$)
    Table China Parkinson Disease Drug Market Share by Type (2014-2019)
    Table China Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table China Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Japan Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Japan Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Japan Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Japan Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Japan Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Japan Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Japan Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Southeast Asia Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Southeast Asia Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Southeast Asia Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure India Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table India Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table India Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table India Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table India Parkinson Disease Drug Market Share by Type (2014-2019)
    Table India Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table India Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Central & South America Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Central & South America Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Central & South America Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Parkinson Disease Drug Market Share by Application (2014-2019)
    Table Merck Company Details
    Table Merck Revenue in Parkinson Disease Drug Business (2014-2019) (Million US$)
    Figure Merck Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Merck Recent Development
    Table Akorn Company Details
    Table Akorn Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Akorn Recent Development
    Table GSK Company Details
    Table GSK Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure GSK Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table GSK Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Novartis Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Boehringer Ingelheim Recent Development
    Table Teva Pharmaceutical Company Details
    Table Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Teva Pharmaceutical Recent Development
    Table Abbvie Company Details
    Table Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Abbvie Recent Development
    Table Kyowa Hakko Kirin Pharma Company Details
    Table Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Kyowa Hakko Kirin Pharma Recent Development
    Table Astellas Pharma Company Details
    Table Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Astellas Pharma Recent Development
    Table Desitin Arzneimittel Company Details
    Table Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Desitin Arzneimittel Recent Development
    Table Endo Pharmaceuticals Company Details
    Table F.Hoffmann-La Roche Company Details
    Table H.Lundbeck Company Details
    Table Valeant Company Details
    Table Apokyn Company Details
    Table Orion Company Details
    Table Stada Arzneimittel Company Details
    Table US WorldMeds Company Details
    Table Valeant Pharmaceuticals Company Details
    Table Global Parkinson Disease Drug Market Size by Regions (Million US$) 2019-2025
    Figure Global Parkinson Disease Drug Market Size Share by Regions (2019-2025)
    Figure Global Parkinson Disease Drug Market Size Share by Regions in 2025
    Figure United States Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure China Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure India Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Table Global Parkinson Disease Drug Market Size by Product (2019-2025) (Million US$)
    Figure Global Parkinson Disease Drug Market Size by Product (2019-2025)
    Figure Global Parkinson Disease Drug Market Size by Product in 2025
    Table Global Parkinson Disease Drug Market Size by Application (2019-2025) (Million US$)
    Figure Global Parkinson Disease Drug Market Size by Application (2019-2025)
    Figure Global Parkinson Disease Drug Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
In 2018, the global Parkinson Disease Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson Disease Drug development in United States, Europe and China.

The key players covered in this study
    Merck
    Akorn
    GSK
    Novartis
    Boehringer Ingelheim
    Teva Pharmaceutical
    Abbvie
    Kyowa Hakko Kirin Pharma
    Astellas Pharma
    Desitin Arzneimittel
    Endo Pharmaceuticals
    F.Hoffmann-La Roche
    H.Lundbeck
    Valeant
    Apokyn
    Orion
    Stada Arzneimittel
    US WorldMeds
    Valeant Pharmaceuticals

Market segment by Type, the product can be split into
    Sinemet-CR
    Trastal
    Madopar
    COMT Inhibitor
    Other

Market segment by Application, split into
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players.
    To present the Parkinson Disease Drug development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson Disease Drug are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Parkinson Disease Drug Market Size Growth Rate by Type (2014-2025)
        1.4.2 Sinemet-CR
        1.4.3 Trastal
        1.4.4 Madopar
        1.4.5 COMT Inhibitor
        1.4.6 Other
    1.5 Market by Application
        1.5.1 Global Parkinson Disease Drug Market Share by Application (2014-2025)
        1.5.2 Under 40 Years Old
        1.5.3 40-65 Years Old
        1.5.4 Above 65 Years Old
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Parkinson Disease Drug Market Size
    2.2 Parkinson Disease Drug Growth Trends by Regions
        2.2.1 Parkinson Disease Drug Market Size by Regions (2014-2025)
        2.2.2 Parkinson Disease Drug Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Parkinson Disease Drug Market Size by Manufacturers
        3.1.1 Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019)
        3.1.2 Global Parkinson Disease Drug Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
    3.2 Parkinson Disease Drug Key Players Head office and Area Served
    3.3 Key Players Parkinson Disease Drug Product/Solution/Service
    3.4 Date of Enter into Parkinson Disease Drug Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Parkinson Disease Drug Market Size by Type (2014-2019)
    4.2 Global Parkinson Disease Drug Market Size by Application (2014-2019)

5 United States
    5.1 United States Parkinson Disease Drug Market Size (2014-2019)
    5.2 Parkinson Disease Drug Key Players in United States
    5.3 United States Parkinson Disease Drug Market Size by Type
    5.4 United States Parkinson Disease Drug Market Size by Application

6 Europe
    6.1 Europe Parkinson Disease Drug Market Size (2014-2019)
    6.2 Parkinson Disease Drug Key Players in Europe
    6.3 Europe Parkinson Disease Drug Market Size by Type
    6.4 Europe Parkinson Disease Drug Market Size by Application

7 China
    7.1 China Parkinson Disease Drug Market Size (2014-2019)
    7.2 Parkinson Disease Drug Key Players in China
    7.3 China Parkinson Disease Drug Market Size by Type
    7.4 China Parkinson Disease Drug Market Size by Application

8 Japan
    8.1 Japan Parkinson Disease Drug Market Size (2014-2019)
    8.2 Parkinson Disease Drug Key Players in Japan
    8.3 Japan Parkinson Disease Drug Market Size by Type
    8.4 Japan Parkinson Disease Drug Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Parkinson Disease Drug Market Size (2014-2019)
    9.2 Parkinson Disease Drug Key Players in Southeast Asia
    9.3 Southeast Asia Parkinson Disease Drug Market Size by Type
    9.4 Southeast Asia Parkinson Disease Drug Market Size by Application

10 India
    10.1 India Parkinson Disease Drug Market Size (2014-2019)
    10.2 Parkinson Disease Drug Key Players in India
    10.3 India Parkinson Disease Drug Market Size by Type
    10.4 India Parkinson Disease Drug Market Size by Application

11 Central & South America
    11.1 Central & South America Parkinson Disease Drug Market Size (2014-2019)
    11.2 Parkinson Disease Drug Key Players in Central & South America
    11.3 Central & South America Parkinson Disease Drug Market Size by Type
    11.4 Central & South America Parkinson Disease Drug Market Size by Application

12 International Players Profiles
    12.1 Merck
        12.1.1 Merck Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Parkinson Disease Drug Introduction
        12.1.4 Merck Revenue in Parkinson Disease Drug Business (2014-2019)
        12.1.5 Merck Recent Development
    12.2 Akorn
        12.2.1 Akorn Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Parkinson Disease Drug Introduction
        12.2.4 Akorn Revenue in Parkinson Disease Drug Business (2014-2019)
        12.2.5 Akorn Recent Development
    12.3 GSK
        12.3.1 GSK Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Parkinson Disease Drug Introduction
        12.3.4 GSK Revenue in Parkinson Disease Drug Business (2014-2019)
        12.3.5 GSK Recent Development
    12.4 Novartis
        12.4.1 Novartis Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Parkinson Disease Drug Introduction
        12.4.4 Novartis Revenue in Parkinson Disease Drug Business (2014-2019)
        12.4.5 Novartis Recent Development
    12.5 Boehringer Ingelheim
        12.5.1 Boehringer Ingelheim Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Parkinson Disease Drug Introduction
        12.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)
        12.5.5 Boehringer Ingelheim Recent Development
    12.6 Teva Pharmaceutical
        12.6.1 Teva Pharmaceutical Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Parkinson Disease Drug Introduction
        12.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)
        12.6.5 Teva Pharmaceutical Recent Development
    12.7 Abbvie
        12.7.1 Abbvie Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Parkinson Disease Drug Introduction
        12.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)
        12.7.5 Abbvie Recent Development
    12.8 Kyowa Hakko Kirin Pharma
        12.8.1 Kyowa Hakko Kirin Pharma Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Parkinson Disease Drug Introduction
        12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
        12.8.5 Kyowa Hakko Kirin Pharma Recent Development
    12.9 Astellas Pharma
        12.9.1 Astellas Pharma Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Parkinson Disease Drug Introduction
        12.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
        12.9.5 Astellas Pharma Recent Development
    12.10 Desitin Arzneimittel
        12.10.1 Desitin Arzneimittel Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Parkinson Disease Drug Introduction
        12.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)
        12.10.5 Desitin Arzneimittel Recent Development
    12.11 Endo Pharmaceuticals
    12.12 F.Hoffmann-La Roche
    12.13 H.Lundbeck
    12.14 Valeant
    12.15 Apokyn
    12.16 Orion
    12.17 Stada Arzneimittel
    12.18 US WorldMeds
    12.19 Valeant Pharmaceuticals

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
Read More
List of Tables and Figures

    Table Parkinson Disease Drug Key Market Segments
    Table Key Players Parkinson Disease Drug Covered
    Table Global Parkinson Disease Drug Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Parkinson Disease Drug Market Size Market Share by Type 2014-2025
    Figure Sinemet-CR Figures
    Table Key Players of Sinemet-CR
    Figure Trastal Figures
    Table Key Players of Trastal
    Figure Madopar Figures
    Table Key Players of Madopar
    Figure COMT Inhibitor Figures
    Table Key Players of COMT Inhibitor
    Figure Other Figures
    Table Key Players of Other
    Table Global Parkinson Disease Drug Market Size Growth by Application 2014-2025 (Million US$)
    Figure Under 40 Years Old Case Studies
    Figure 40-65 Years Old Case Studies
    Figure Above 65 Years Old Case Studies
    Figure Parkinson Disease Drug Report Years Considered
    Table Global Parkinson Disease Drug Market Size 2014-2025 (Million US$)
    Figure Global Parkinson Disease Drug Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Parkinson Disease Drug Market Size by Regions 2014-2025 (Million US$)
    Table Global Parkinson Disease Drug Market Size by Regions 2014-2019 (Million US$)
    Table Global Parkinson Disease Drug Market Share by Regions 2014-2019
    Figure Global Parkinson Disease Drug Market Share by Regions 2014-2019
    Figure Global Parkinson Disease Drug Market Share by Regions 2019
    Table Market Top Trends
    Table Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Share by Manufacturers (2014-2019)
    Figure Global Parkinson Disease Drug Market Share by Manufacturers in 2018
    Table Global Parkinson Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Parkinson Disease Drug Product/Solution/Service
    Table Date of Enter into Parkinson Disease Drug Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Size Share by Type (2014-2019)
    Figure Global Parkinson Disease Drug Market Size Market Share by Type (2014-2019)
    Table Global Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Global Parkinson Disease Drug Market Size Share by Application (2014-2019)
    Figure Global Parkinson Disease Drug Market Size Market Share by Application (2014-2019)
    Figure Global Parkinson Disease Drug Revenue Market Share by Application in 2018
    Figure United States Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table United States Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table United States Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table United States Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table United States Parkinson Disease Drug Market Share by Type (2014-2019)
    Table United States Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table United States Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Europe Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Europe Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Europe Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Europe Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Europe Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Europe Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Europe Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure China Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table China Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table China Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table China Parkinson Disease Drug Market Size by Type (2014-20189) (Million US$)
    Table China Parkinson Disease Drug Market Share by Type (2014-2019)
    Table China Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table China Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Japan Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Japan Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Japan Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Japan Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Japan Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Japan Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Japan Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Southeast Asia Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Southeast Asia Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Southeast Asia Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure India Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table India Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table India Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table India Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table India Parkinson Disease Drug Market Share by Type (2014-2019)
    Table India Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table India Parkinson Disease Drug Market Share by Application (2014-2019)
    Figure Central & South America Parkinson Disease Drug Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Parkinson Disease Drug Market Share (2018-2019)
    Table Central & South America Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Parkinson Disease Drug Market Share by Type (2014-2019)
    Table Central & South America Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Parkinson Disease Drug Market Share by Application (2014-2019)
    Table Merck Company Details
    Table Merck Revenue in Parkinson Disease Drug Business (2014-2019) (Million US$)
    Figure Merck Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Merck Recent Development
    Table Akorn Company Details
    Table Akorn Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Akorn Recent Development
    Table GSK Company Details
    Table GSK Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure GSK Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table GSK Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Novartis Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Boehringer Ingelheim Recent Development
    Table Teva Pharmaceutical Company Details
    Table Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Teva Pharmaceutical Recent Development
    Table Abbvie Company Details
    Table Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Abbvie Recent Development
    Table Kyowa Hakko Kirin Pharma Company Details
    Table Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Kyowa Hakko Kirin Pharma Recent Development
    Table Astellas Pharma Company Details
    Table Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Astellas Pharma Recent Development
    Table Desitin Arzneimittel Company Details
    Table Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
    Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
    Table Desitin Arzneimittel Recent Development
    Table Endo Pharmaceuticals Company Details
    Table F.Hoffmann-La Roche Company Details
    Table H.Lundbeck Company Details
    Table Valeant Company Details
    Table Apokyn Company Details
    Table Orion Company Details
    Table Stada Arzneimittel Company Details
    Table US WorldMeds Company Details
    Table Valeant Pharmaceuticals Company Details
    Table Global Parkinson Disease Drug Market Size by Regions (Million US$) 2019-2025
    Figure Global Parkinson Disease Drug Market Size Share by Regions (2019-2025)
    Figure Global Parkinson Disease Drug Market Size Share by Regions in 2025
    Figure United States Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure China Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure India Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
    Table Global Parkinson Disease Drug Market Size by Product (2019-2025) (Million US$)
    Figure Global Parkinson Disease Drug Market Size by Product (2019-2025)
    Figure Global Parkinson Disease Drug Market Size by Product in 2025
    Table Global Parkinson Disease Drug Market Size by Application (2019-2025) (Million US$)
    Figure Global Parkinson Disease Drug Market Size by Application (2019-2025)
    Figure Global Parkinson Disease Drug Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Anosmia Market Size Status and Forecast 2021 2027
Global Anosmia Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-27U4147
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Epidermal Growth Factor EGF CAS 62253 63 8 Market Research Report 2021
Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-2Y4709
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Catechin Market Research Report 2021
Global Catechin Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-39V4149
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0